|
Re: Article
|
5
|
Resverlogix Corp.
|
May 29, 2022 07:23PM
|
|
Re: Concerns Mount Over COVID-19 'Rebounds' After Treatment With Pfizer's Paxlovid
|
8
|
Resverlogix Corp.
|
Jun 02, 2022 01:26PM
|
|
Re: Apropos AGM
|
4
|
Resverlogix Corp.
|
Jun 08, 2022 02:58PM
|
|
Re: New insights from this study -- Questions for scientists.
|
2
|
Resverlogix Corp.
|
Jun 08, 2022 03:05PM
|
|
Re: New insights from this study -- Questions for scientists.
|
4
|
Resverlogix Corp.
|
Jun 09, 2022 11:38AM
|
|
Re: Hepalink
|
2
|
Resverlogix Corp.
|
Jun 13, 2022 01:18PM
|
|
Re: Another article. Mechanism related.
|
3
|
Resverlogix Corp.
|
Jun 13, 2022 09:06PM
|
|
Re: Level 2 Quotes this morning
|
1
|
Resverlogix Corp.
|
Jun 16, 2022 02:29PM
|
|
Re: Level 2 Quotes this morning
|
1
|
Resverlogix Corp.
|
Jun 16, 2022 05:12PM
|
|
Re: Level 2 Quotes this morning
|
2
|
Resverlogix Corp.
|
Jun 16, 2022 10:11PM
|
|
Re: LINK for the AGM
|
3
|
Resverlogix Corp.
|
Jun 21, 2022 04:14PM
|
|
Re: LINK for the AGM
|
2
|
Resverlogix Corp.
|
Jun 21, 2022 07:24PM
|
|
Re: Where are the Questions ?
|
4
|
Resverlogix Corp.
|
Jun 21, 2022 07:32PM
|
|
Re: More insider buying
|
2
|
Resverlogix Corp.
|
Jun 27, 2022 11:05AM
|
|
Re: Question re BOD votes
|
4
|
Resverlogix Corp.
|
Jun 27, 2022 11:45AM
|
|
Re: More insider buying
|
4
|
Resverlogix Corp.
|
Jun 27, 2022 01:15PM
|
|
Re: Question re BOD votes
|
3
|
Resverlogix Corp.
|
Jun 27, 2022 02:18PM
|
|
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
|
1
|
Zenith Epigenetics
|
Jun 28, 2022 07:42PM
|
|
Re: Gilead's GS-5829 flops in mCRPC
|
2
|
Zenith Epigenetics
|
Jul 19, 2022 04:42PM
|
|
Re: Gilead's GS-5829 flops in mCRPC
|
3
|
Zenith Epigenetics
|
Jul 20, 2022 09:26AM
|
